Telemedicine Market By Component (Software, Hardware, Services), By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology, Other Applications), By End User (Healthcare Provider, Payer, Healthcare Consumers): Global Opportunity Analysis and Industry Forecast, 2023-2032
The Telemedicine Market was valued for $84.2 billion in 2022 and is estimated to reach $451.4 billion by 2032, exhibiting a CAGR of 18.3% from 2023 to 2032. Telemedicine can be defined as delivering remote healthcare services in real time to patients by electronic audio-visual solutions. Telemedicine helps the health care professionals to evaluate the health conditions, diagnose and treat the patients from a distance using telecommunications technology. The benefit of telemedicine is the ease it provides to patients who are using telemedicine and practitioners by reducing and eliminating the need for in-person visit to receive medical treatment. It is useful for routine check-ups, minor illnesses, medication management, and chronic disease monitoring. By eliminating the need for physical visits, telemedicine also help to reduce healthcare costs associated with transportation and missed work.
The telemedicine market growth is driven by an increase in need for patient management, surge in product launches, and shift of preference toward remote patient monitoring. The proliferation of smart devices and the ability of high-quality video opened up the possibility of delivering remote healthcare to patients in their homes, workplaces, or assisted living facilities. This new technology products increased the demand for telemedicine which, in turn, drives the growth of the market. For instance, in March 2023, Philips, a global health technology company, launched its Philips Virtual Care Management portfolio to help health systems, providers, payers, and employer groups. Philips Virtual Care Management can help reduce pressure on hospital staff by decreasing emergency department visits, as well as reducing the cost of care through better management of chronic disease.
Furthermore, advancements in the telemedicine technology such as reliable internet connectivity in the developed regions and highly improved video conferencing are making telemedicine more accessible. In addition, the emergence of smartwatches and other wearable devices to monitor a wide range of health conditions, from heart rate to sleep patterns, also boosts the growth of telemedicine market. Moreover, various software applications are being developed to assist in remote diagnoses. For instance, dermatology apps such as miiskin can allow patients to upload photos of their skin for analysis. However, the use of telemedicine solutions without proper security may lead to huge losses of confidential and critical information.
In addition, smartphones with telemedicine applications are vulnerable to various cyber threats due to low firewall safety. For instance, according to the World Economic Forum, cyber-attacks are considered as the top five risks to global stability. This could adversely affect the results and credibility of the companies, thereby impeding market growth.
On the other hand, development of advanced telecommunications solutions such as devices and software and increase in government funding and policies for telemedicine are expected to create lucrative opportunities for market growth during the forecast period. For instance, in April 2020, MyDoc partnered with First Medicine Corporation, a technology-driven healthcare company, to provide free access to the telemedicine solution in the U.S. for 3 months.
The telemedicine market is segmented on the basis of component, application, end user, and region. On the basis of component, the market is segmented into software, hardware, and services. As per application, the market is categorized into teleradiology, telepsychiatry, telepathology, teledermatology, telecardiology, and other applications. By end user, it is divided into healthcare providers, payers, and healthcare consumers.
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global telemedicine market are AMC Health, American Well Corporation, Cerner Corporation, Cisco Systems, Inc., General Electric Company, Koninklijke Philips N.V., Cigna Corporation, Siemens AG, Teladoc Health, Inc., and Medtronic Plc.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the telemedicine market analysis from 2022 to 2032 to identify the prevailing telemedicine market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the telemedicine market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global telemedicine market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Component
Software
Hardware
Services
By Application
Teleradiology
Telepsychiatry
Telepathology
Teledermatology
Telecardiology
Other Applications
By End User
Healthcare Provider
Payer
Healthcare Consumers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Medtronic plc
Included Health Inc.
American Well Corporation
Oracle Corporation
General Electric Company
Koninklijke Philips N.V.
Teladoc Health Inc.
The Cigna Group
Siemens AG
AMC Health, LLC
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. High threat of new entrants
- 3.3.3. High threat of substitutes
- 3.3.4. Moderate intensity of rivalry
- 3.3.5. Moderate bargaining power of buyers
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Rise in demand for remote healthcare
- 3.4.1.2. Technological advancement in telemedicine
- 3.4.2. Restraints
- 3.4.2.1. Poor infrastructure and connectivity limitations
- 3.4.3. Opportunities
- 3.4.3.1. Increase in government initiatives and policies
- CHAPTER 4: TELEMEDICINE MARKET, BY COMPONENT
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Software
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Hardware
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.4. Services
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- CHAPTER 5: TELEMEDICINE MARKET, BY APPLICATION
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Teleradiology
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Telepsychiatry
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.4. Telepathology
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
- 5.5. Teledermatology
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country
- 5.6. Telecardiology
- 5.6.1. Key market trends, growth factors and opportunities
- 5.6.2. Market size and forecast, by region
- 5.6.3. Market share analysis by country
- 5.7. Other Applications
- 5.7.1. Key market trends, growth factors and opportunities
- 5.7.2. Market size and forecast, by region
- 5.7.3. Market share analysis by country
- CHAPTER 6: TELEMEDICINE MARKET, BY END USER
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Healthcare Provider
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Payer
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Healthcare Consumers
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- CHAPTER 7: TELEMEDICINE MARKET, BY REGION
- 7.1. Overview
- 7.1.1. Market size and forecast By Region
- 7.2. North America
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by Component
- 7.2.3. Market size and forecast, by Application
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
- 7.2.5.1. U.S.
- 7.2.5.1.1. Market size and forecast, by Component
- 7.2.5.1.2. Market size and forecast, by Application
- 7.2.5.1.3. Market size and forecast, by End User
- 7.2.5.2. Canada
- 7.2.5.2.1. Market size and forecast, by Component
- 7.2.5.2.2. Market size and forecast, by Application
- 7.2.5.2.3. Market size and forecast, by End User
- 7.2.5.3. Mexico
- 7.2.5.3.1. Market size and forecast, by Component
- 7.2.5.3.2. Market size and forecast, by Application
- 7.2.5.3.3. Market size and forecast, by End User
- 7.3. Europe
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by Component
- 7.3.3. Market size and forecast, by Application
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
- 7.3.5.1. Germany
- 7.3.5.1.1. Market size and forecast, by Component
- 7.3.5.1.2. Market size and forecast, by Application
- 7.3.5.1.3. Market size and forecast, by End User
- 7.3.5.2. France
- 7.3.5.2.1. Market size and forecast, by Component
- 7.3.5.2.2. Market size and forecast, by Application
- 7.3.5.2.3. Market size and forecast, by End User
- 7.3.5.3. UK
- 7.3.5.3.1. Market size and forecast, by Component
- 7.3.5.3.2. Market size and forecast, by Application
- 7.3.5.3.3. Market size and forecast, by End User
- 7.3.5.4. Italy
- 7.3.5.4.1. Market size and forecast, by Component
- 7.3.5.4.2. Market size and forecast, by Application
- 7.3.5.4.3. Market size and forecast, by End User
- 7.3.5.5. Spain
- 7.3.5.5.1. Market size and forecast, by Component
- 7.3.5.5.2. Market size and forecast, by Application
- 7.3.5.5.3. Market size and forecast, by End User
- 7.3.5.6. Rest of Europe
- 7.3.5.6.1. Market size and forecast, by Component
- 7.3.5.6.2. Market size and forecast, by Application
- 7.3.5.6.3. Market size and forecast, by End User
- 7.4. Asia-Pacific
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by Component
- 7.4.3. Market size and forecast, by Application
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
- 7.4.5.1. Japan
- 7.4.5.1.1. Market size and forecast, by Component
- 7.4.5.1.2. Market size and forecast, by Application
- 7.4.5.1.3. Market size and forecast, by End User
- 7.4.5.2. China
- 7.4.5.2.1. Market size and forecast, by Component
- 7.4.5.2.2. Market size and forecast, by Application
- 7.4.5.2.3. Market size and forecast, by End User
- 7.4.5.3. India
- 7.4.5.3.1. Market size and forecast, by Component
- 7.4.5.3.2. Market size and forecast, by Application
- 7.4.5.3.3. Market size and forecast, by End User
- 7.4.5.4. Australia
- 7.4.5.4.1. Market size and forecast, by Component
- 7.4.5.4.2. Market size and forecast, by Application
- 7.4.5.4.3. Market size and forecast, by End User
- 7.4.5.5. South Korea
- 7.4.5.5.1. Market size and forecast, by Component
- 7.4.5.5.2. Market size and forecast, by Application
- 7.4.5.5.3. Market size and forecast, by End User
- 7.4.5.6. Rest of Asia-Pacific
- 7.4.5.6.1. Market size and forecast, by Component
- 7.4.5.6.2. Market size and forecast, by Application
- 7.4.5.6.3. Market size and forecast, by End User
- 7.5. LAMEA
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by Component
- 7.5.3. Market size and forecast, by Application
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
- 7.5.5.1. Brazil
- 7.5.5.1.1. Market size and forecast, by Component
- 7.5.5.1.2. Market size and forecast, by Application
- 7.5.5.1.3. Market size and forecast, by End User
- 7.5.5.2. Saudi Arabia
- 7.5.5.2.1. Market size and forecast, by Component
- 7.5.5.2.2. Market size and forecast, by Application
- 7.5.5.2.3. Market size and forecast, by End User
- 7.5.5.3. South Africa
- 7.5.5.3.1. Market size and forecast, by Component
- 7.5.5.3.2. Market size and forecast, by Application
- 7.5.5.3.3. Market size and forecast, by End User
- 7.5.5.4. Rest of LAMEA
- 7.5.5.4.1. Market size and forecast, by Component
- 7.5.5.4.2. Market size and forecast, by Application
- 7.5.5.4.3. Market size and forecast, by End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top player positioning, 2022
- CHAPTER 9: COMPANY PROFILES
- 9.1. AMC Health, LLC
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Key strategic moves and developments
- 9.2. American Well Corporation
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.2.7. Key strategic moves and developments
- 9.3. Oracle Corporation
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
- 9.4. General Electric Company
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
- 9.4.7. Key strategic moves and developments
- 9.5. Koninklijke Philips N.V.
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
- 9.5.7. Key strategic moves and developments
- 9.6. The Cigna Group
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business performance
- 9.7. Teladoc Health Inc.
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.7.6. Business performance
- 9.7.7. Key strategic moves and developments
- 9.8. Medtronic plc
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Business performance
- 9.8.7. Key strategic moves and developments
- 9.9. Included Health Inc.
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.10. Siemens AG
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
- 9.10.7. Key strategic moves and developments
- LIST OF TABLES
- TABLE 01. GLOBAL TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 02. TELEMEDICINE MARKET FOR SOFTWARE, BY REGION, 2022-2032 ($MILLION)
- TABLE 03. TELEMEDICINE MARKET FOR HARDWARE, BY REGION, 2022-2032 ($MILLION)
- TABLE 04. TELEMEDICINE MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
- TABLE 05. GLOBAL TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 06. TELEMEDICINE MARKET FOR TELERADIOLOGY, BY REGION, 2022-2032 ($MILLION)
- TABLE 07. TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY REGION, 2022-2032 ($MILLION)
- TABLE 08. TELEMEDICINE MARKET FOR TELEPATHOLOGY, BY REGION, 2022-2032 ($MILLION)
- TABLE 09. TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY REGION, 2022-2032 ($MILLION)
- TABLE 10. TELEMEDICINE MARKET FOR TELECARDIOLOGY, BY REGION, 2022-2032 ($MILLION)
- TABLE 11. TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2032 ($MILLION)
- TABLE 12. GLOBAL TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 13. TELEMEDICINE MARKET FOR HEALTHCARE PROVIDER, BY REGION, 2022-2032 ($MILLION)
- TABLE 14. TELEMEDICINE MARKET FOR PAYER, BY REGION, 2022-2032 ($MILLION)
- TABLE 15. TELEMEDICINE MARKET FOR HEALTHCARE CONSUMERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 16. TELEMEDICINE MARKET, BY REGION, 2022-2032 ($MILLION)
- TABLE 17. NORTH AMERICA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 18. NORTH AMERICA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 19. NORTH AMERICA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 20. NORTH AMERICA TELEMEDICINE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 21. U.S. TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 22. U.S. TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 23. U.S. TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 24. CANADA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 25. CANADA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 26. CANADA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 27. MEXICO TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 28. MEXICO TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 29. MEXICO TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 30. EUROPE TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 31. EUROPE TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 32. EUROPE TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 33. EUROPE TELEMEDICINE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 34. GERMANY TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 35. GERMANY TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 36. GERMANY TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 37. FRANCE TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 38. FRANCE TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 39. FRANCE TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 40. UK TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 41. UK TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 42. UK TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 43. ITALY TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 44. ITALY TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 45. ITALY TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 46. SPAIN TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 47. SPAIN TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 48. SPAIN TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 49. REST OF EUROPE TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 50. REST OF EUROPE TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 51. REST OF EUROPE TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 52. ASIA-PACIFIC TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 53. ASIA-PACIFIC TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 54. ASIA-PACIFIC TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 55. ASIA-PACIFIC TELEMEDICINE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 56. JAPAN TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 57. JAPAN TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 58. JAPAN TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 59. CHINA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 60. CHINA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 61. CHINA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 62. INDIA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 63. INDIA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 64. INDIA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 65. AUSTRALIA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 66. AUSTRALIA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 67. AUSTRALIA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 68. SOUTH KOREA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 69. SOUTH KOREA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 70. SOUTH KOREA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 71. REST OF ASIA-PACIFIC TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 72. REST OF ASIA-PACIFIC TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 73. REST OF ASIA-PACIFIC TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 74. LAMEA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 75. LAMEA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 76. LAMEA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 77. LAMEA TELEMEDICINE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 78. BRAZIL TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 79. BRAZIL TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 80. BRAZIL TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 81. SAUDI ARABIA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 82. SAUDI ARABIA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 83. SAUDI ARABIA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 84. SOUTH AFRICA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 85. SOUTH AFRICA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 86. SOUTH AFRICA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 87. REST OF LAMEA TELEMEDICINE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
- TABLE 88. REST OF LAMEA TELEMEDICINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 89. REST OF LAMEA TELEMEDICINE MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 90. AMC HEALTH, LLC: KEY EXECUTIVES
- TABLE 91. AMC HEALTH, LLC: COMPANY SNAPSHOT
- TABLE 92. AMC HEALTH, LLC: PRODUCT SEGMENTS
- TABLE 93. AMC HEALTH, LLC: SERVICE SEGMENTS
- TABLE 94. AMC HEALTH, LLC: PRODUCT PORTFOLIO
- TABLE 95. AMC HEALTH, LLC: KEY STRATERGIES
- TABLE 96. AMERICAN WELL CORPORATION: KEY EXECUTIVES
- TABLE 97. AMERICAN WELL CORPORATION: COMPANY SNAPSHOT
- TABLE 98. AMERICAN WELL CORPORATION: SERVICE SEGMENTS
- TABLE 99. AMERICAN WELL CORPORATION: PRODUCT PORTFOLIO
- TABLE 100. AMERICAN WELL CORPORATION: KEY STRATERGIES
- TABLE 101. ORACLE CORPORATION: KEY EXECUTIVES
- TABLE 102. ORACLE CORPORATION: COMPANY SNAPSHOT
- TABLE 103. ORACLE CORPORATION: SERVICE SEGMENTS
- TABLE 104. ORACLE CORPORATION: PRODUCT PORTFOLIO
- TABLE 105. GENERAL ELECTRIC COMPANY: KEY EXECUTIVES
- TABLE 106. GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
- TABLE 107. GENERAL ELECTRIC COMPANY: PRODUCT SEGMENTS
- TABLE 108. GENERAL ELECTRIC COMPANY: PRODUCT PORTFOLIO
- TABLE 109. GENERAL ELECTRIC COMPANY: KEY STRATERGIES
- TABLE 110. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
- TABLE 111. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
- TABLE 112. KONINKLIJKE PHILIPS N.V.: SERVICE SEGMENTS
- TABLE 113. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
- TABLE 114. KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
- TABLE 115. THE CIGNA GROUP: KEY EXECUTIVES
- TABLE 116. THE CIGNA GROUP: COMPANY SNAPSHOT
- TABLE 117. THE CIGNA GROUP: SERVICE SEGMENTS
- TABLE 118. THE CIGNA GROUP: PRODUCT PORTFOLIO
- TABLE 119. TELADOC HEALTH INC.: KEY EXECUTIVES
- TABLE 120. TELADOC HEALTH INC.: COMPANY SNAPSHOT
- TABLE 121. TELADOC HEALTH INC.: SERVICE SEGMENTS
- TABLE 122. TELADOC HEALTH INC.: PRODUCT PORTFOLIO
- TABLE 123. TELADOC HEALTH INC.: KEY STRATERGIES
- TABLE 124. MEDTRONIC PLC: KEY EXECUTIVES
- TABLE 125. MEDTRONIC PLC: COMPANY SNAPSHOT
- TABLE 126. MEDTRONIC PLC: PRODUCT SEGMENTS
- TABLE 127. MEDTRONIC PLC: PRODUCT PORTFOLIO
- TABLE 128. MEDTRONIC PLC: KEY STRATERGIES
- TABLE 129. INCLUDED HEALTH INC.: KEY EXECUTIVES
- TABLE 130. INCLUDED HEALTH INC.: COMPANY SNAPSHOT
- TABLE 131. INCLUDED HEALTH INC.: SERVICE SEGMENTS
- TABLE 132. INCLUDED HEALTH INC.: PRODUCT PORTFOLIO
- TABLE 133. SIEMENS AG: KEY EXECUTIVES
- TABLE 134. SIEMENS AG: COMPANY SNAPSHOT
- TABLE 135. SIEMENS AG: PRODUCT SEGMENTS
- TABLE 136. SIEMENS AG: PRODUCT PORTFOLIO
- TABLE 137. SIEMENS AG: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 01. TELEMEDICINE MARKET, 2022-2032
- FIGURE 02. SEGMENTATION OF TELEMEDICINE MARKET,2022-2032
- FIGURE 03. TOP INVESTMENT POCKETS IN TELEMEDICINE MARKET (2023-2032)
- FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 05. HIGH THREAT OF NEW ENTRANTS
- FIGURE 06. HIGH THREAT OF SUBSTITUTES
- FIGURE 07. MODERATE INTENSITY OF RIVALRY
- FIGURE 08. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 09. GLOBAL TELEMEDICINE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 10. TELEMEDICINE MARKET, BY COMPONENT, 2022 AND 2032(%)
- FIGURE 11. COMPARATIVE SHARE ANALYSIS OF TELEMEDICINE MARKET FOR SOFTWARE, BY COUNTRY 2022 AND 2032(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF TELEMEDICINE MARKET FOR HARDWARE, BY COUNTRY 2022 AND 2032(%)
- FIGURE 13. COMPARATIVE SHARE ANALYSIS OF TELEMEDICINE MARKET FOR SERVICES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 14. TELEMEDICINE MARKET, BY APPLICATION, 2022 AND 2032(%)
- FIGURE 15. COMPARATIVE SHARE ANALYSIS OF TELEMEDICINE MARKET FOR TELERADIOLOGY, BY COUNTRY 2022 AND 2032(%)
- FIGURE 16. COMPARATIVE SHARE ANALYSIS OF TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY COUNTRY 2022 AND 2032(%)
- FIGURE 17. COMPARATIVE SHARE ANALYSIS OF TELEMEDICINE MARKET FOR TELEPATHOLOGY, BY COUNTRY 2022 AND 2032(%)
- FIGURE 18. COMPARATIVE SHARE ANALYSIS OF TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY COUNTRY 2022 AND 2032(%)
- FIGURE 19. COMPARATIVE SHARE ANALYSIS OF TELEMEDICINE MARKET FOR TELECARDIOLOGY, BY COUNTRY 2022 AND 2032(%)
- FIGURE 20. COMPARATIVE SHARE ANALYSIS OF TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 21. TELEMEDICINE MARKET, BY END USER, 2022 AND 2032(%)
- FIGURE 22. COMPARATIVE SHARE ANALYSIS OF TELEMEDICINE MARKET FOR HEALTHCARE PROVIDER, BY COUNTRY 2022 AND 2032(%)
- FIGURE 23. COMPARATIVE SHARE ANALYSIS OF TELEMEDICINE MARKET FOR PAYER, BY COUNTRY 2022 AND 2032(%)
- FIGURE 24. COMPARATIVE SHARE ANALYSIS OF TELEMEDICINE MARKET FOR HEALTHCARE CONSUMERS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 25. TELEMEDICINE MARKET BY REGION, 2022 AND 2032(%)
- FIGURE 26. U.S. TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 27. CANADA TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 28. MEXICO TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 29. GERMANY TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 30. FRANCE TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 31. UK TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 32. ITALY TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 33. SPAIN TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 34. REST OF EUROPE TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 35. JAPAN TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 36. CHINA TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 37. INDIA TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 38. AUSTRALIA TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 39. SOUTH KOREA TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 40. REST OF ASIA-PACIFIC TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 41. BRAZIL TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 42. SAUDI ARABIA TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 43. SOUTH AFRICA TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 44. REST OF LAMEA TELEMEDICINE MARKET, 2022-2032 ($MILLION)
- FIGURE 45. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
- FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
- FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
- FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 49. COMPETITIVE DASHBOARD
- FIGURE 50. COMPETITIVE HEATMAP: TELEMEDICINE MARKET
- FIGURE 51. TOP PLAYER POSITIONING, 2022
- FIGURE 52. AMERICAN WELL CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 53. AMERICAN WELL CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 54. ORACLE CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 55. ORACLE CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
- FIGURE 56. ORACLE CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 57. ORACLE CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 58. GENERAL ELECTRIC COMPANY: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 59. GENERAL ELECTRIC COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 60. GENERAL ELECTRIC COMPANY: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 61. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)
- FIGURE 62. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 63. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 64. THE CIGNA GROUP: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 65. THE CIGNA GROUP: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 66. TELADOC HEALTH INC.: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 67. TELADOC HEALTH INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 68. TELADOC HEALTH INC.: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 69. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
- FIGURE 70. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 71. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 72. SIEMENS AG: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 73. SIEMENS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 74. SIEMENS AG: REVENUE SHARE BY REGION, 2022 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook